Ever Supreme Bio Technology Co., Ltd (6712.TWO)
TWD 156.0
(-9.83%)
TWD 156.0
(-9.83%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.07 Billion TWD | 5.18% |
| 2022 | 1.97 Billion TWD | -2.42% |
| 2021 | 2.02 Billion TWD | 135.65% |
| 2020 | 858.32 Million TWD | -5.76% |
| 2019 | 910.75 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.8 Billion TWD | -15.6% |
| 2024 Q1 | 2.13 Billion TWD | 2.85% |
| 2023 Q4 | 2.07 Billion TWD | 6.99% |
| 2023 FY | 2.07 Billion TWD | 5.18% |
| 2023 Q3 | 1.94 Billion TWD | -3.52% |
| 2023 Q2 | 2.01 Billion TWD | -4.81% |
| 2023 Q1 | 2.11 Billion TWD | 7.04% |
| 2022 FY | 1.97 Billion TWD | -2.42% |
| 2022 Q4 | 1.97 Billion TWD | 0.0% |
| 2021 FY | 2.02 Billion TWD | 135.65% |
| 2020 FY | 858.32 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -1521.217% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 28.439% |
| Level Biotechnology Inc. | 822.67 Million TWD | -152.338% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -212.299% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -278.301% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 46.688% |
| GlycoNex Incorporation | 1.55 Billion TWD | -33.688% |
| VBI | 452.1 Million TWD | -359.171% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | -76.502% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -177.318% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -448.66% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -83.087% |
| Visgeneer Inc. | 397.17 Million TWD | -422.67% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 44.942% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 3.85% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -135.073% |
| Neith Corporation | 192.15 Million TWD | -980.347% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 65.927% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -2722.154% |
| Enimmune corporation | 604.82 Million TWD | -243.225% |
| TaiRx, Inc. | 833.74 Million TWD | -148.987% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 32.732% |
| EirGenix Inc. | 11.16 Billion TWD | 81.403% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -262.202% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | -21.231% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 42.283% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -97.616% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -589.601% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -684.381% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -370.526% |
| RBC Bioscience Corporation | 753.79 Million TWD | -175.398% |
| BiOptic Inc. | 613.77 Million TWD | -238.223% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | -16.712% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -79.003% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -221.923% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 33.17% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -1303.274% |
| NaviFUS Corp. | 490.53 Million TWD | -323.195% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -69.364% |
| Sinew Pharma Inc. | 1.36 Billion TWD | -52.263% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -292.315% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -78.745% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | -25.336% |
| AP Biosciences Inc | 890.75 Million TWD | -133.051% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 75.655% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -540.424% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | -55.658% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 23.428% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 86.488% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -406.004% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -423.098% |
| TCI GENE Inc. | 1.16 Billion TWD | -78.047% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -604.703% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | -52.268% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -120.43% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -197.218% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 47.497% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 45.695% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -68.796% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 62.956% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -95.471% |
| Acepodia, Inc. | 6.81 Billion TWD | 69.555% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 45.749% |